The field of antibody-drug conjugates (ADCs) has gained significant momentum after the recent regulatory approval of two ADCs, and significant research efforts are directed to identify more effective payloads and simplify current manufacturing challenges.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jm501298k | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!